232 related articles for article (PubMed ID: 18245644)
21. First reported case of aplastic anemia occurring in a patient after acute promyelocytic leukemia in remission.
Pham A; Bahadini B; Alsabeh R; Steinberg A
Clin Adv Hematol Oncol; 2009 Oct; 7(10):670-4. PubMed ID: 20040907
[No Abstract] [Full Text] [Related]
22. Central nervous system relapse of acute promyelocytic leukemia.
Johnston DL; Mandel K
Pediatr Blood Cancer; 2010 Feb; 54(2):336-7; author reply 338. PubMed ID: 19847884
[No Abstract] [Full Text] [Related]
23. Isolated central nervous system recurrence of acute promyelocytic leukemia in children.
Chow J; Feusner J
Pediatr Blood Cancer; 2009 Jan; 52(1):11-3. PubMed ID: 18816805
[TBL] [Abstract][Full Text] [Related]
24. [Acute promyelocytic leukemia with central nervous system leukemia--a report of two cases].
Kobayashi Y; Takahashi S; Mizuno T; Ozawa M; Horiuchi H; Maruo M; Kondo M
Gan No Rinsho; 1988 Aug; 34(9):1153-8. PubMed ID: 3172521
[TBL] [Abstract][Full Text] [Related]
25. Favourable outcome in an APL patient with PLZF/RARalpha fusion gene: quantitative real-time RT-PCR confirms molecular response.
Cassinat B; Guillemot I; Moluçon-Chabrot C; Zassadowski F; Fenaux P; Tournilhac O; Chomienne C
Haematologica; 2006 Dec; 91(12 Suppl):ECR58. PubMed ID: 17194664
[TBL] [Abstract][Full Text] [Related]
26. Histopathological response of transitional cell carcinoma to arsenic trioxide during the treatment of concurrently diagnosed acute promyelocytic leukaemia.
Krishna R; Sorour Y; Goepel JR; Kirkbride P; Smith DJ; Ezaydi Y; Dalley CD; Snowden JA
Clin Oncol (R Coll Radiol); 2008 Dec; 20(10):769-71. PubMed ID: 18995171
[No Abstract] [Full Text] [Related]
27. Resistance to therapy in acute promyelocytic leukemia.
Lehmann-Che J; Bally C; de Thé H
N Engl J Med; 2014 Sep; 371(12):1170-2. PubMed ID: 25229938
[No Abstract] [Full Text] [Related]
28. Relapse of acute promyelocytic leukemia presenting as granulocytic sarcoma in the hip.
Agarwal N; Tepe EM; Mishra A; Ward JH
Ann Hematol; 2006 Oct; 85(10):741-2. PubMed ID: 16718497
[No Abstract] [Full Text] [Related]
29. [Leukemia cutis in acute promyelocytic leukemia].
del Río Garma J; Varela Gómez MR; Torres Carrete JP; Batlle Fonrodona FJ
Sangre (Barc); 1997 Feb; 42(1):87-8. PubMed ID: 9229813
[No Abstract] [Full Text] [Related]
30. Therapy-related acute myeloid leukemia after successful therapy for acute promyelocytic leukemia with t(15;17): A case report and literature review.
Bao L; Lu X; Lai Y; Zhang X; Zhu H; Liu Y; Qin Y; Huang XJ
Leuk Res; 2009 Jul; 33(7):e64-8. PubMed ID: 19297021
[No Abstract] [Full Text] [Related]
31. Morphologic heterogeneity of acute promyelocytic leukemia: therapy-related acute promyelocytic leukemia presenting with FAB-M2 morphology.
Sinha S; Aish L; Oo TH
Am J Hematol; 2006 Jun; 81(6):475-6. PubMed ID: 16680741
[No Abstract] [Full Text] [Related]
32. Central nervous system relapse in acute promyelocytic leukaemia treated with ATRA.
Currie J; Chee YL; Culligan DJ
Br J Haematol; 1997 Nov; 99(2):469. PubMed ID: 9375778
[No Abstract] [Full Text] [Related]
33. Activity of all-trans-retinoic acid in a case of central nervous system extramedullary relapse of acute promyelocytic leukemia.
Patriarca F; Filì C; Geromin A; Sperotto A; Prosdocimo S; Fanin R
Eur J Haematol; 2002 May; 68(5):310-3. PubMed ID: 12144538
[TBL] [Abstract][Full Text] [Related]
34. Central nervous system involvement in relapsed acute promyelocytic leukemia.
Kaspers G; Gibson B; Grimwade D; Pession A; Smith O; Testi AM
Pediatr Blood Cancer; 2009 Aug; 53(2):235-6; author reply 237. PubMed ID: 19353622
[No Abstract] [Full Text] [Related]
35. Central nervous system involvement at first relapse in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy without intrathecal prophylaxis.
Montesinos P; Díaz-Mediavilla J; Debén G; Prates V; Tormo M; Rubio V; Pérez I; Fernández I; Viguria M; Rayón C; González J; de la Serna J; Esteve J; Bergua JM; Rivas C; González M; González JD; Negri S; Brunet S; Lowenberg B; Sanz MA
Haematologica; 2009 Sep; 94(9):1242-9. PubMed ID: 19608685
[TBL] [Abstract][Full Text] [Related]
36. Clonal stability of initial leukemia in a child with central nervous system relapse 7.4 years after bone marrow relapse of common acute lymphoblastic leukemic.
Eckert C; Einsiedel HG; Hartmann R; von Stackelberg A; Völpel S; Guggemos A; Hanzsch N; Kawan L; Seeger K; Henze G
Haematologica; 2004 Jul; 89(7):ECR23. PubMed ID: 15257960
[TBL] [Abstract][Full Text] [Related]
37. Introducing biological features at diagnosis improves the relapse risk stratification in patients with acute promyelocytic leukemia treated with ATRA and chemotherapy.
Breccia M; Stefania de Propris M; Molica M; Colafigli G; Minotti C; Diverio D; Latagliata R; Guarini A; Lo-Coco F; Foà R
Am J Hematol; 2015 Sep; 90(9):E181-2. PubMed ID: 26119985
[No Abstract] [Full Text] [Related]
38. AIDA treatment for high-risk acute promyelocytic leukemia in a pregnant woman at 21 weeks of gestation.
Breccia M; Cimino G; Alimena G; De Carolis S; Lo Coco F; Mandelli F
Haematologica; 2002 Feb; 87(2):ELT12. PubMed ID: 11836189
[No Abstract] [Full Text] [Related]
39. Acute promyelocytic leukemia: new issues on pathogenesis and treatment response.
Vitoux D; Nasr R; de The H
Int J Biochem Cell Biol; 2007; 39(6):1063-70. PubMed ID: 17468032
[TBL] [Abstract][Full Text] [Related]
40. Arsenic trioxide and mannitol for the treatment of acute promyelocytic leukemia relapse in the central nervous system.
Wang H; Cao F; Li J; Li L; Li Y; Shi C; Lan W; Li D; Zhao H; Zhang Y; Zhang Z; Liu X; Meng R; Yang B; Zhou J
Blood; 2014 Sep; 124(12):1998-2000. PubMed ID: 24963041
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
